News from lexicon pharmaceuticals, inc

Jul 09, 2014, 07:00 ET

Lexicon And JDRF Collaborate For Phase 2 Clinical Trial Of LX4211 In Type 1 Diabetes

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that JDRF, the world's largest non-profit supporter of type 1 diabetes (T1D)...

Jul 07, 2014, 16:15 ET

Lexicon Announces Appointment of Lonnel Coats as President and Chief Executive Officer

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lonnel Coats has been appointed president and chief executive officer...

Jun 14, 2014, 13:15 ET

Lexicon Presents LX4211 Data at American Diabetes Association Meeting

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), presented data at the 74th Scientific Sessions of the American Diabetes Association (ADA) in San...

May 30, 2014, 17:00 ET

Lexicon To Present At The Jefferies 2014 Global Healthcare Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the Jefferies 2014 Global Healthcare...

May 09, 2014, 07:00 ET

Lexicon To Present At The 2014 Bank of America Merrill Lynch Healthcare Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the 2014 Bank of America Merrill Lynch...

May 08, 2014, 06:00 ET

Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2014 First Quarter Financial Results

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, today...

May 05, 2014, 07:00 ET

Lexicon To Report First Quarter 2014 Financial Results On May 8, 2014

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, will...

Apr 14, 2014, 06:00 ET

LX4211 Achieves Positive Results In Type 1 Diabetes Clinical Trial

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today positive, top-line results in a Phase 2 clinical trial of LX4211 in type 1...

Apr 03, 2014, 07:00 ET

Lexicon To Present At The 2014 Needham Healthcare Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the Needham Healthcare Conference on...

Feb 28, 2014, 07:00 ET

Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2013 Fourth Quarter And Full Year Financial Results

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease,...

Feb 20, 2014, 07:00 ET

Lexicon to Report Fourth Quarter and Year End 2013 Financial Results on February 28, 2014

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, will...

Feb 03, 2014, 06:00 ET

Lexicon To Present At The BIO CEO And Investor Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the BIO CEO & Investor...

Jan 13, 2014, 06:00 ET

Lexicon Announces Focus On Late-Stage Development Programs And Preparation For Commercialization

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today it is focusing its resources on its late-stage drug development programs, principally...

Jan 08, 2014, 06:00 ET

Lexicon To Present At The J.P. Morgan Healthcare Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Arthur Sands, M.D., Ph.D., President and Chief Executive Officer, will...

Dec 03, 2013, 06:00 ET

Lexicon Completes Phase 2 Study Of LX1033 In IBS-d

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced top-line results from an initial Phase 2 study exploring the use of LX1033 in...

Dec 02, 2013, 06:00 ET

Lexicon Pharmaceuticals To Host 2013 Research And Development Day

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) will hold its  R&D Day on Thursday, December 5, 2013 from 9:00 a.m. to 12:00 p.m....

Nov 15, 2013, 06:00 ET

Lexicon To Present At The Jefferies Global Healthcare Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the Jefferies Global Healthcare...

Nov 12, 2013, 06:00 ET

Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2013 Third Quarter Financial Results

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for...

Nov 07, 2013, 06:00 ET

Lexicon To Present At The Credit Suisse Healthcare Conference

THE WOODLANDS, Texas, Nov. 7, 2013 /PRNewswire/-- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will...

Nov 06, 2013, 06:00 ET

Lexicon To Report Third Quarter Financial Results On November 12, 2013

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease,...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer